TerminatedNCT03853876

A Natural History Study of Aspartylglucosaminuria

Studying Aspartylglucosaminuria

Last synced from ClinicalTrials.gov May 4, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Neurogene Inc.
Principal Investigator: Elise Beausoleil
Neurogene Inc.
Enrollment: 8 enrolled
Eligibility: All sexes
Timeline: 2019 – 2022

Study locations (1)

University of Texas Southwestern, Dallas, Texas, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03853876 on ClinicalTrials.gov

← Back to all trials